Literature DB >> 27241371

Human infections due to Staphylococcus pseudintermedius, an emerging zoonosis of canine origin: report of 24 cases.

R Somayaji1, M A R Priyantha2, J E Rubin2, D Church3.   

Abstract

BACKGROUND: Staphylococcus pseudintermedius has been recently identified as a novel species within the genus Staphylococcus, and is commonly associated with infections in dogs. Currently, there are few reports of human infections due to this bacterium.
OBJECTIVE: To use a population-based approach to describe the characteristics of human S. pseudintermedius infections in a large Canadian healthcare region.
METHODS: All adult cases aged ≥18 years identified at a large regional laboratory from April 1, 2013 to April 1, 2015 who had at least one positive culture for S. pseudintermedius were retrospectively reviewed. A combination of phenotypic methods, mass spectrometry (i.e., MALDI-TOF), and cpn60 sequencing were used to identify S. pseudintermedius. Chart review was conducted, and cases were analysed descriptively.
RESULTS: Twenty-seven isolates of S. pseudintermedius from 24 human cases were included for analysis. 58.3% were male with median age of 61 years (IQR 55-70.5). Most patients [22 (92.1%)] had confirmed contact with dogs at time of infection. S. pseudintermedius was isolated in 18 cases (75.0%) of skin and soft tissue infections (SSTI), and 2 invasive cases (8.3%) including a prosthetic joint and bloodstream infection. The other 4 patients were considered to be colonized (skin - 3; lung - 1). Methicillin resistance was identified in 3 cases with 6 total isolates (22.2%); multi-drug resistance was also demonstrated commonly.
CONCLUSION: S. pseudintermedius is most commonly associated with SSTIs in humans. Transmission probably occurs from a pet dog. Species-level identification of S. pseudintermedius is important due to the high prevalence of antibiotic resistance, particularly to methicillin.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Human infection; Methicillin resistance; Staphylococcus pseudintermedius; Zoonosis

Mesh:

Year:  2016        PMID: 27241371     DOI: 10.1016/j.diagmicrobio.2016.05.008

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  51 in total

1.  Epidemiology, Clinical Characteristics, and Antimicrobial Susceptibility Profiles of Human Clinical Isolates of Staphylococcus intermedius Group.

Authors:  Melanie L Yarbrough; William Lainhart; C A Burnham
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

2.  Characterization of the First mecA-Positive Multidrug-Resistant Staphylococcus pseudintermedius Isolated from an Argentinian Patient.

Authors:  Paula Gagetti; Laura Errecalde; Alice R Wattam; Denise De Belder; Matthew Ojeda Saavedra; Alejandra Corso; Adriana E Rosato
Journal:  Microb Drug Resist       Date:  2020-02-07       Impact factor: 3.431

3.  Deimmunized Lysostaphin Synergizes with Small-Molecule Chemotherapies and Resensitizes Methicillin-Resistant Staphylococcus aureus to β-Lactam Antibiotics.

Authors:  Yongliang Fang; Jack R Kirsch; Liang Li; Seth A Brooks; Spencer Heim; Cynthia Tan; Susan Eszterhas; Hao D Cheng; Hongliang Zhao; Yan Q Xiong; Karl E Griswold
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

4.  Performance of Five Commercial Identification Platforms for Identification of Staphylococcus delphini.

Authors:  David A Bemis; Karen C Carroll; Lars F Westblade; Matthew C Canver; Tsigereda Tekle; Samantha T Compton; Katrina Callan; Eileen M Burd; Barbara L Zimmer
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

5.  Identification of Staphylococcus pseudintermedius Isolates from Wound Cultures by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Improves Accuracy of Susceptibility Reporting at an Increase in Cost.

Authors:  Helen L Bibby; Kristen L Brown
Journal:  J Clin Microbiol       Date:  2021-08-11       Impact factor: 5.948

6.  Bacteriocin BacSp222 and Its Succinylated Forms Exhibit Proinflammatory Activities Toward Innate Immune Cells .

Authors:  Justyna Śmiałek; Monika Bzowska; Alicja Hinz; Renata Mężyk-Kopeć; Kamilla Sołtys; Paweł Mak
Journal:  J Inflamm Res       Date:  2022-08-12

7.  Molecular Epidemiology of Clinical and Colonizing Methicillin-Resistant Staphylococcus Isolates in Companion Animals.

Authors:  Hester Rynhoud; Brian M Forde; Scott A Beatson; Sam Abraham; Erika Meler; Ricardo J Soares Magalhães; Justine S Gibson
Journal:  Front Vet Sci       Date:  2021-04-23

8.  Staphylococcus pseudintermedius Bacteremia in a Lung Transplant Recipient Exposed to Domestic Pets.

Authors:  Coulter Small; Norman Beatty; Guy El Helou
Journal:  Cureus       Date:  2021-05-07

9.  Comparative Performances of Vitek-2, Disk Diffusion, and Broth Microdilution for Antimicrobial Susceptibility Testing of Canine Staphylococcus pseudintermedius.

Authors:  Elisa Rampacci; Michele Trotta; Caterina Fani; Serenella Silvestri; Valentina Stefanetti; Chiara Brachelente; Antonella Mencacci; Fabrizio Passamonti
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

10.  Genomic insights into methicillin-resistant Staphylococcus pseudintermedius isolates from dogs and humans of the same sequence types reveals diversity in prophages and pathogenicity islands.

Authors:  Nathita Phumthanakorn; Sybille Schwendener; Valentina Donà; Pattrarat Chanchaithong; Vincent Perreten; Nuvee Prapasarakul
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.